Drugs / MTX=Methotrexate
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02882087 Background | Oct 2015 → Feb 2019 | rheumatoid arthritis | RemeGen Co., Ltd. | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX=Methotrexate | “MTX=Methotrexate” NCT02882087 ↗ |
| Known as | MTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02882087 ↗ |